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Transforming Growth Factor-beta (TGFb) and activin A
(actA) are members of the TGFb superfamily and display
overlapping biological activities, including the ability to
promote the conversion of conventional CD4 T cells to
regulatory T cells (Tregs). We have recently shown that in
situ vaccination by local tumor irradiation is hindered by
activation of latent TGFb (Vanpouille-Box et al., Cancer
Res 2015). Intriguingly, while TGFb blockade enhanced
activation of dendritic cells and T cell priming, it did
increase rather than reduce intratumoral Tregs. Because
there is evidence that actA and TGFb pathway cross-regu-
late each other, we tested the hypothesis that upregulation
of actA by RT in the presence of TGFb blockade may be
responsible for the observed Tregs increase within the
tumor.
Secretion of actA by untreated and irradiated 4T1 tumor
cells was quantified by ELISA. 4T1 derivatives with condi-
tional actA knockdown (4T1shActA) or non-silencing con-
trol (4T1shNS) were engineered using inducible tetracycline
plasmids and injected s.c. in BALB/c mice (day 0). ActA
gene knockdown was induced by doxycyline at day 8.
TGFb neutralizing 1D11 or isotype control antibodies
were given i.p. every other day starting on day 12. RT was
delivered to the primary tumor in 6Gy fractions on five
consecutive days starting at day 13. Mice were followed
for tumor growth or euthanized at day 22 for analysis.
RT significantly increased actA secretion by 4T1 cells
(pActA gene expression was upregulated in irradiated
4T1-tumors but was significantly higher in mice treated
with 1D11 and RT+1D11. Neither in vivo 1D11 nor
ActA gene knockdown by themselves affected tumor
growth. However, each intervention significantly
improved tumor control achieved by RT. TGFb block-
ade in mice bearing irradiated 4T1shActA-tumors did not
further improve tumor control but did significantly
increase IFNΥ production by CD8+ T cells in response
to a tumor-specific antigen. Surprisingly, inhibiting
TGFb or actA increased intratumoral Tregs. The
increase in Tregs induced by RT was markedly larger in
the presence of 1D11 or actA knockdown. In marked
contrast, when both TGFb and actA were inhibited
Tregs numbers significantly decreased below baseline in
irradiated tumors (Control: 11.6%; 1D11: 26.2%, shActA:
21%; 1D11+shActA: 13.6%; RT: 15.7%; RT+1D11: 27.5%;
RT+shActA: 30.3%; RT+1D11+shActA: 7.9% of Tregs).
These data suggest a complex regulation of Tregs in
the tumor by TGFb and actA. Combined blockade of
TGFb and actA during RT may be required to optimize
activation of anti-tumor T cells induced by RT.
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